Severe 6-thioguanine-induced marrow aplasia in a child with acute lymphoblastic leukemia and inherited thiopurine methyltransferase deficiency

Kim L. McBride, Gerald S. Gilchrist, W. Anthony Smithson, Richard M Weinshilboum, Carol L. Szumlanski

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

6-thioguanine (6TG) is undergoing investigation for use in the maintenance phase of acute lymphoblastic leukemia (ALL). Just as with 6-mercaptopurine (6MP), it is be expected that 6TG would cause pancytopenia in individuals with inherited thiopurine methyltransferase (TPMT) deficiency. We report the first case of severe and prolonged pancytopenia caused by 6-thioguanine in an 8-year-old boy with ALL and inherited TPMT deficiency. Neutropenia lasted 67 days, whereas anemia and thrombocytopenia did not recover for 96 days. To obviate this life-threatening complication, clinicians should consider assaying TPMT activity before initiating therapy with 6MP and, particularly, 6TG in children with ALL.

Original languageEnglish (US)
Pages (from-to)441-445
Number of pages5
JournalJournal of Pediatric Hematology/Oncology
Volume22
Issue number5
StatePublished - Sep 2000

Fingerprint

Thioguanine
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Bone Marrow
6-Mercaptopurine
Pancytopenia
thiopurine methyltransferase
Neutropenia
Thrombocytopenia
Anemia
Maintenance
Thiopurine S methyltranferase deficiency

Keywords

  • Complications
  • Drug eruption
  • Pharmacogenetics
  • Therapy

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Oncology
  • Hematology

Cite this

Severe 6-thioguanine-induced marrow aplasia in a child with acute lymphoblastic leukemia and inherited thiopurine methyltransferase deficiency. / McBride, Kim L.; Gilchrist, Gerald S.; Smithson, W. Anthony; Weinshilboum, Richard M; Szumlanski, Carol L.

In: Journal of Pediatric Hematology/Oncology, Vol. 22, No. 5, 09.2000, p. 441-445.

Research output: Contribution to journalArticle

@article{503b6a82180f4e15b90446a91c568dba,
title = "Severe 6-thioguanine-induced marrow aplasia in a child with acute lymphoblastic leukemia and inherited thiopurine methyltransferase deficiency",
abstract = "6-thioguanine (6TG) is undergoing investigation for use in the maintenance phase of acute lymphoblastic leukemia (ALL). Just as with 6-mercaptopurine (6MP), it is be expected that 6TG would cause pancytopenia in individuals with inherited thiopurine methyltransferase (TPMT) deficiency. We report the first case of severe and prolonged pancytopenia caused by 6-thioguanine in an 8-year-old boy with ALL and inherited TPMT deficiency. Neutropenia lasted 67 days, whereas anemia and thrombocytopenia did not recover for 96 days. To obviate this life-threatening complication, clinicians should consider assaying TPMT activity before initiating therapy with 6MP and, particularly, 6TG in children with ALL.",
keywords = "Complications, Drug eruption, Pharmacogenetics, Therapy",
author = "McBride, {Kim L.} and Gilchrist, {Gerald S.} and Smithson, {W. Anthony} and Weinshilboum, {Richard M} and Szumlanski, {Carol L.}",
year = "2000",
month = "9",
language = "English (US)",
volume = "22",
pages = "441--445",
journal = "Journal of Pediatric Hematology/Oncology",
issn = "1077-4114",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Severe 6-thioguanine-induced marrow aplasia in a child with acute lymphoblastic leukemia and inherited thiopurine methyltransferase deficiency

AU - McBride, Kim L.

AU - Gilchrist, Gerald S.

AU - Smithson, W. Anthony

AU - Weinshilboum, Richard M

AU - Szumlanski, Carol L.

PY - 2000/9

Y1 - 2000/9

N2 - 6-thioguanine (6TG) is undergoing investigation for use in the maintenance phase of acute lymphoblastic leukemia (ALL). Just as with 6-mercaptopurine (6MP), it is be expected that 6TG would cause pancytopenia in individuals with inherited thiopurine methyltransferase (TPMT) deficiency. We report the first case of severe and prolonged pancytopenia caused by 6-thioguanine in an 8-year-old boy with ALL and inherited TPMT deficiency. Neutropenia lasted 67 days, whereas anemia and thrombocytopenia did not recover for 96 days. To obviate this life-threatening complication, clinicians should consider assaying TPMT activity before initiating therapy with 6MP and, particularly, 6TG in children with ALL.

AB - 6-thioguanine (6TG) is undergoing investigation for use in the maintenance phase of acute lymphoblastic leukemia (ALL). Just as with 6-mercaptopurine (6MP), it is be expected that 6TG would cause pancytopenia in individuals with inherited thiopurine methyltransferase (TPMT) deficiency. We report the first case of severe and prolonged pancytopenia caused by 6-thioguanine in an 8-year-old boy with ALL and inherited TPMT deficiency. Neutropenia lasted 67 days, whereas anemia and thrombocytopenia did not recover for 96 days. To obviate this life-threatening complication, clinicians should consider assaying TPMT activity before initiating therapy with 6MP and, particularly, 6TG in children with ALL.

KW - Complications

KW - Drug eruption

KW - Pharmacogenetics

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=0034263837&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034263837&partnerID=8YFLogxK

M3 - Article

C2 - 11037857

AN - SCOPUS:0034263837

VL - 22

SP - 441

EP - 445

JO - Journal of Pediatric Hematology/Oncology

JF - Journal of Pediatric Hematology/Oncology

SN - 1077-4114

IS - 5

ER -